Pathstone Holdings, LLC

Position in ABBV — AbbVie Inc.

CIK 2011612 ENGLEWOOD, NJ

Position in ABBV

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$53,830,948

-$524,994 QoQ

Shares Held

247,510

+4.0% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 37.60090501393883.ToString("F0")% Shared 0.6876489838794392.ToString("F0")% None 61.711446002181724.ToString("F0")%

Healthcare · as of Mar 31, 2026

Pathstone Holdings, LLC holds $479,605,626 across 16 Drug Manufacturers - General names. ABBV ranks #4 (11.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	115,489	$106,223,316
2	JNJ	Johnson & Johnson	391,963	$95,811,435
3	MRK	Merck & Co., Inc.	480,635	$57,815,583
4	ABBV	AbbVie Inc. This page	247,510	$53,830,948
5	AZN	Astrazeneca PLC	170,432	$33,612,597
6	AMGN	Amgen Inc	92,288	$32,471,531
7	NVS	Novartis AG	136,897	$20,911,015
8	PFE	Pfizer Inc	635,026	$17,831,528

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$53,830,948	247,510	+4.0%	Shares	Sole	2026-05-11
2025-12-31	$54,355,942	237,892	+2.7%	Shares	Other	2026-02-13
2025-09-30	$53,612,391	231,547	+2.6%	Shares	Defined	2025-11-13
2025-06-30	$41,904,456	225,754	-8.1%	Shares	Other	2025-08-12
2025-03-31	$51,475,082	245,681	+2.1%	Shares	Sole	2025-05-15
2024-12-31	$42,750,353	240,576	-0.7%	Shares	Other	2025-02-14
2024-09-30	$47,861,843	242,363	-1.1%	Shares	Defined	2024-11-07
2024-06-30	$42,015,023	244,957	-0.4%	Shares	Sole	2024-08-14
2024-03-31	$44,797,692	246,006	-1.4%	Shares	Sole	2024-05-13
2023-12-31	$38,663,928	249,493	—	Shares	Other	2024-02-14
No filing history on record for this holder in this stock.